BIBLIOGRAFÍA 1. APPELQVIST P, SALMO M. Prognosis in carcinoma of the male breast. Acta Chir Scand 1982; 148: 499-502 2. CIATTO S, IOSSA A, BONARDI R. Male breast carcinoma: review of a multicenter series of 150 cases. Tumori 1990; 76: 555-558. 3. SALVADORI B, SACCOZZI R, MANZARI A, ANDREOLA S, CONTI RA, CUSUMANO F, GRASSI M. Prognosis of breast cancer in males: an analysis of 170 cases. Eur J Cancer 1954; 30ª: 930-935. 4. FLEMING A. On a remarkable bacteriolotic element found in tissues and secretions. Proc Roy Soc London 1922; B93: 306-317. 5. PETRAKIS NL. Physiologic, biochemical and cytologic aspects of the nipple aspirate fluid. Breast Cancer Res Treat 1986; 8: 7-19. 6. BIGGAR WD, STURGESS JM. Role of lysozyme in the microbicidal activity of rat alveolar macrofhages. Infection Immunol 1977; 16: 974-982. 7. KLOKARS ML, ROBERS P. Stimulation of phagocytosis by human lysozyme. Acta Haematol 1976; 52: 289-295. 8. SÁNCHEZ LM, VIZOSO F, DÍEZ-ITZA I, LÓPEZ-OTÍN C. Identification of the major protein componens in breast secretions from women with bening and malignant breast diseases. Cancer Res 1992; 52: 95-100. 9. VIZOSO F, SÁNCHEZ LM, DÍEZ-ITZA I, LAMELAS ML, LÓPEZ-OTÍN C. Factors affecting protein composition of breast secretions from nonlactating women. Breast Cancer Res Treat 1992; 23: 251-258. 10. VIZOSO F, DÍEZ-ITZA I, SÁNCHEZ LM, RUIBAL A, LÓPEZ-OTÍN C. Relationship between prolactin levels and composition of breast secretions in nonlactating women. J Clin Endocinol Metab 1994; 79: 525-529. 11. VIZOSO F, PLAZA E, VÁZQUEZ J,SERRA C, LAMELAS ML, GONZÁLEZ LO, MERINO AM, MDEZ J: Lysozyme expresión by breast carcinomas, correlation with clinicopathologic parameters, and prognostic significance. Ann Surg Oncol 2001, 8:667-674. 12. BLOOM HJG, RICHARDSON WW. Histological grading and prognosis in breast cancer. Br J Cancer 1957; 11: 359-377. 13. McCARTY KS, SZABO E, FLOWERS JL, COX EB, LEIGHT GS, MILLER L, KDNRAT HI, SOPER JT, BUDWIT DA, CREASMAN WT, SEIGLER HT, McCARTY KS Sr. Use of a monoclonal anti-estrogen receptor antibody in the inmunohistochemical evaluation of human tumors. Cancer Res 1986; 46: 4244-4248. 14. KAPLAN EL, MEIER P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481 15. MANTEL M, MYERS M. Problems of convergence of maximum likelihood iterative procedures in muliparameter situations. J Am Stat Assoc 1971; 66: 484-491 16. COX DR. Regression models and life tables. J R Stat Soc B 1972; 34: 187-220. 17. DIXONWJ, BROWN MB, ENGELMAN L, FRANE JW, HILL MA, JENNRICH RI et al: BMDP statistical software. Berkeley: University of California Press; 1985. 18. TOPPER YJ, FREEMAN CS. Multiple hormone interactions in the developmental biology of the mammary gland. Physiol Rev 1989; 60: 1049-1106. 19. GINSBURG E, VONDERHAAR BK. Prolactin syntesis and secretion by human breast cancer cells. Cancer Res 1995; 55: 2591-2595. 20. HOLDAWAY MI, FRIESEN HG. Hormone binding by human mammary carcinoma. Cancer Res 1977; 37: 1946-1952. 21. PARTRIDGE RK, HAHNEL R. Prolactin receptors in human breast carcinoma. Cancer 1979;43: 643-646. 22. TURCOT LEMAY L, KELLY PA. Prolactin in human breast tumors. J Natl Cancer Inst 1982; 68: 381-383 23. BONNETERRE J, PEYRAT JP, VANDEWALLE B, BEUSCART R, VIE MC, CAPPELAERE P. Prolactin receptors in human breast cancer. Eur J Cancer 1982; 18: 1157-1162 24. TOURAINE F, MARTINI JF, ZAFRANI B, DURAND JC, LABAILLE F, MALET C, NICOLAS A, TRIVIN C, POSTEL-VINAY MC, KUTTENN F, KELLY PA. Increased expression of prolactin receptor gene assessed by quantitative polymerase chain reaction in human breast tumors versus normal breast tissues. J Clin Endocrinol Met.1998; 83: 667-674. 25. PEYRAT JP, DJIANE J, BONNETERRE J, VANDEWALLE B, VENNIN PH, DELOBELLE A, DEPADT G, LEFEBVRE J. Stimulation of DNA syntesis by prolactin in human breast tumor explants. Relation to prolactin receptors. Anticancer Res 1984; 4: 257-262. 26. CRICHLOW RW, GALT SW. Male breast cancer. Surg Clin North Am 1990; 70: 1165-1177. 27. ADAMI HL, HAULINEN T, EWETZ M: The survival pattern in male breast cancer: an analysis of 1429 patients from the Nordic countries. Cancer 1989, 64:1177-1182. 28. HELLER KS, ROSEN PP, SCHOTTENFELD D. Male breast cancer: a clinicopathologic study of 97 cases. Ann Surg 1978; 188: 60-65. 29. SERRA C, VIZOSO F, LAMELAS ML, RODRIGUEZ JC, MERINO AM, GONZALEZ LO, BALTASAR A, PÉREZ-VÁZQUEZ MT, MEDRANO J: Comparative studyof two androgen-induced (Apolipoprotein D and Pepsinogen C) prognostic markers between female and male breast carcinoma. Int J Surg Invest 2000, 2:183-192. 30. WEBER-CHAPPUIS K, BIERI-BURGER S, HURLIMANN J. Comparison of pronostic markers detected by immuno-histoquemistry in male and female breast carcinomas. Eur J Cancer 1996; 32: 1686-1692
|